Letters to HCPs

Important information for Healthcare Professionals

DHPC: GLOBAL RECALL of Zerbaxa (ceftolozane / tazobactam) 1 g/0.5 g powder for concentrate for solution for infusion

This letter to HCPs gives details around the global recall of the product in December 2020 and the advice to immediately discontinue its use.

For Healthcare Professionals